|
TDP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.724000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.159900E-02 |
| Normal-vs-Stage2 |
4.601200E-01 |
| Normal-vs-Stage3 |
3.760800E-01 |
| Normal-vs-Stage4 |
9.639800E-01 |
| Stage1-vs-Stage2 |
1.313600E-02 |
| Stage1-vs-Stage3 |
9.784400E-04 |
| Stage1-vs-Stage4 |
9.885800E-02 |
| Stage2-vs-Stage3 |
9.797800E-01 |
| Stage2-vs-Stage4 |
5.197000E-01 |
| Stage3-vs-Stage4 |
4.409200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.171000E-01 |
| Normal-vs-AfricanAmerican |
3.608800E-01 |
| Normal-vs-Asian |
4.720800E-01 |
| Caucasian-vs-AfricanAmerican |
5.893600E-01 |
| Caucasian-vs-Asian |
7.500600E-01 |
| AfricanAmerican-vs-Asian |
9.291000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.612600E-01 |
| Normal-vs-Female |
9.160200E-02 |
| Male-vs-Female |
8.642100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.869400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.009400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.374800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.322800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.579600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.735400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.196600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.454600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.816600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.955400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.238200E-04 |
| Normal-vs-Grade 2 |
2.817700E-02 |
| Normal-vs-Grade 3 |
6.034000E-01 |
| Normal-vs-Grade 4 |
9.646600E-01 |
| Grade 1-vs-Grade 2 |
3.398100E-02 |
| Grade 1-vs-Grade 3 |
2.024700E-03 |
| Grade 1-vs-Grade 4 |
2.259000E-03 |
| Grade 2-vs-Grade 3 |
1.555290E-03 |
| Grade 2-vs-Grade 4 |
1.141810E-01 |
| Grade 3-vs-Grade 4 |
7.474600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.301030E-01 |
| Normal-vs-ccB subtype |
9.452800E-01 |
| ccA subtype-vs-ccB subtype |
1.163640E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.030200E-01 |
| Normal-vs-N1 |
3.248800E-01 |
| N0-vs-N1 |
2.443400E-01 |
|
|
